(Q47940722)

6 February 2018

title

TGF-beta: a link between immunosuppression, nephrotoxicity, and CsA. (English)

1 reference

6 February 2018

1 reference

Khanna AK

1

1 reference

6 February 2018

Cairns VR

series ordinal

2

1 reference

6 February 2018

Becker CG

series ordinal

3

1 reference

6 February 2018

Hosenpud JD

series ordinal

4

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 June 1998

1 reference

6 February 2018

Transplantation Proceedings

published in

1 reference

6 February 2018

volume

30

1 reference

6 February 2018

issue

4

1 reference

6 February 2018

page(s)

944-945

1 reference

6 February 2018

Regulation of transforming growth factor-beta 1 (TGF-beta 1) expression with a novel TGF-beta 1 complementary DNA.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Cyclosporine stimulates expression of transforming growth factor-beta in renal cells. Possible mechanism of cyclosporines antiproliferative effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Regulation of transforming growth factor-beta 1 and its receptor by cyclosporine in human T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Cyclosporine enhances the expression of TGF-beta in the juxtaglomerular cells of the rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Role of transforming growth factor-beta 1 in experimental chronic cyclosporine nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Inhibition of T-cell activity by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Transforming growth factor beta 1 inhibits interleukin-1-induced but enhances ionomycin-induced interferon-gamma production in a T cell lymphoma: comparison with the effects of rapamycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

The glioblastoma-derived T-cell suppressor factor/transforming growth factor beta 2 inhibits the generation of lymphokine-activated killer (LAK) cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Selective suppression of an early step in human B cell activation by cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Inhibition of in vitro anti-DNA B-cell responses by cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Cyclosporine induces elevated procollagen alpha 1 (I) mRNA levels in the rat renal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Immunohistochemical localization of bone morphogenetic protein (BMP) in calcifying fibrous epulis

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

Pathology of recombinant human transforming growth factor-beta 1 in rats and rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2898%2900102-X

7 January 2021

10.1016/S0041-1345(98)00102-X

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018